Knight Therapeutics Inc. (TSX:GUD)
6.23
-0.11 (-1.74%)
At close: Mar 3, 2026
Knight Therapeutics Employees
Knight Therapeutics had 745 employees as of December 31, 2024. The number of employees increased by 20 or 2.76% compared to the previous year.
Employees
745
Change (1Y)
20
Growth (1Y)
2.76%
Revenue / Employee
555.50K CAD
Profits / Employee
-4.69K CAD
Market Cap
617.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 745 | 20 | 2.76% | 745 | 0 |
| Dec 31, 2023 | 725 | 27 | 3.87% | 725 | 0 |
| Dec 31, 2022 | 698 | 38 | 5.76% | 698 | 0 |
| Dec 31, 2021 | 660 | -19 | -2.80% | 660 | 0 |
| Dec 31, 2020 | 679 | - | - | 679 | 0 |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trulieve Cannabis | 6,000 |
| Green Thumb Industries | 4,800 |
| Verano Holdings | 3,800 |
| Cresco Labs | 2,900 |
| TerrAscend | 1,163 |
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Canopy Growth | 960 |
Knight Therapeutics News
- 13 days ago - Incyte (INCY) Expands Latin American Partnership with Knight Therapeutics - GuruFocus
- 13 days ago - Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil - GlobeNewsWire
- 13 days ago - Knight Therapeutics Announces Regulatory Submission of NIKTIMVO (Axatilimab) in Brazil - Wallstreet:Online
- 2 months ago - Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris - GlobeNewsWire
- 4 months ago - Knight Therapeutics Inc. (GUD:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Knight Therapeutics Reports Third Quarter 2025 Results - GlobeNewsWire
- 4 months ago - Knight Announces Closing of US$100 Million Revolving Credit Facility - GlobeNewsWire
- 4 months ago - Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call - GlobeNewsWire